136 related articles for article (PubMed ID: 1940064)
1. Leydig cell tumor estrogen secretion: suppression by a gonadotropin releasing hormone agonist.
Valensi P; Coussieu C; Killian E; Tran-Quang N; Attali JR; Sebaoun J
J Endocrinol Invest; 1991; 14(7):583-9. PubMed ID: 1940064
[TBL] [Abstract][Full Text] [Related]
2. Pituitary-testicular function of prostatic cancer patients during treatment with a gonadotropin-releasing hormone agonist analog. I. Circulating hormone levels.
Huhtaniemi I; Nikula H; Rannikko S
J Androl; 1987; 8(6):355-62. PubMed ID: 3123445
[TBL] [Abstract][Full Text] [Related]
3. Evidence of oestradiol-induced changes in gonadotrophin secretion in men with feminizing Leydig cell tumours.
Kuhn JM; Duranteau L; Rieu MA; Lahlou N; Roger M; Luton JP
Eur J Endocrinol; 1994 Aug; 131(2):160-6. PubMed ID: 8075785
[TBL] [Abstract][Full Text] [Related]
4. Leydig cell tumor: a case report with reference to its endocrinological features.
Masumori N; Kumamoto Y; Itoh N; Tsukamoto T; Miyao N; Koroku M; Hirose T; Takahashi S
Eur Urol; 1993; 24(2):302-4. PubMed ID: 8375456
[TBL] [Abstract][Full Text] [Related]
5. Luteinizing hormone regulation by sex steroids in men with germinal and Leydig cell tumours.
Reznik Y; Rieu M; Kuhn JM; Mandard JC; Bottet P; Lemonnier D; Bekka S; Mahoudeau J
Clin Endocrinol (Oxf); 1993 May; 38(5):487-93. PubMed ID: 8392454
[TBL] [Abstract][Full Text] [Related]
6. Contraception with an LHRH agonist: effect on gonadotrophin and steroid secretion patterns.
Kuhl H; Jung C; Taubert HD
Clin Endocrinol (Oxf); 1984 Aug; 21(2):179-88. PubMed ID: 6432376
[TBL] [Abstract][Full Text] [Related]
7. Response of circulating gonadotropin levels to GnRH agonist treatment in prostatic cancer.
Huhtaniemi I; Venho P; Jacobi G; Rannikko S
J Androl; 1991; 12(1):46-53. PubMed ID: 1901309
[TBL] [Abstract][Full Text] [Related]
8. Leydig cell tumor with gynecomastia: hormonal effects of an estrogen-producing tumor.
Bercovici JP; Tater D; Khoury S; Charles JF; Floch J; Leroy JP
J Clin Endocrinol Metab; 1981 Dec; 53(6):1291-6. PubMed ID: 6795227
[TBL] [Abstract][Full Text] [Related]
9. Pituitary-testicular function of prostatic cancer patients during treatment with a gonadotropin-releasing hormone agonist analog. II. Endocrinology and histology of the testis.
Huhtaniemi I; Nikula H; Parvinen M; Rannikko S
J Androl; 1987; 8(6):363-73. PubMed ID: 3123446
[TBL] [Abstract][Full Text] [Related]
10. Hormonal effects of gonadotropin-releasing hormone (GnRH) agonist in the human male. III. Effects of long term combined treatment with GnRH agonist and androgen.
Bhasin S; Heber D; Steiner BS; Handelsman DJ; Swerdloff RS
J Clin Endocrinol Metab; 1985 May; 60(5):998-1003. PubMed ID: 3920237
[TBL] [Abstract][Full Text] [Related]
11. Hormonal and seminal evaluation of Leydig cell tumour patients before and after orchiectomy.
Zarrilli S; Lombardi G; Paesano L; Di Somma C; Colao A; Mirone V; De Rosa M
Andrologia; 2000 May; 32(3):147-54. PubMed ID: 10863969
[TBL] [Abstract][Full Text] [Related]
12. Leydig cell tumor with gynecomastia: further studies--the recovery after unilateral orchidectomy.
Bercovici JP; Nahoul K; Ducasse M; Tater D; Kerlan V; Scholler R
J Clin Endocrinol Metab; 1985 Nov; 61(5):957-62. PubMed ID: 3930556
[TBL] [Abstract][Full Text] [Related]
13. Gonadal regulation of gonadotropin subunit gene expression: evidence for regulation of follicle-stimulating hormone-beta messenger ribonucleic acid by nonsteroidal hormones in female rats.
Dalkin AC; Haisenleder DJ; Ortolano GA; Suhr A; Marshall JC
Endocrinology; 1990 Aug; 127(2):798-806. PubMed ID: 2115433
[TBL] [Abstract][Full Text] [Related]
14. Serum bioactive and immunoreactive follicle-stimulating hormone in prostatic cancer patients during gonadotropin-releasing hormone agonist treatment and after orchidectomy.
Huhtaniemi IT; Dahl KD; Rannikko S; Hsueh AJ
J Clin Endocrinol Metab; 1988 Feb; 66(2):308-13. PubMed ID: 3123510
[TBL] [Abstract][Full Text] [Related]
15. Testosterone differentially modulates gonadotropin subunit messenger ribonucleic acid responses to gonadotropin-releasing hormone pulse amplitude.
Iliff-Sizemore SA; Ortolano GA; Haisenleder DJ; Dalkin AC; Krueger KA; Marshall JC
Endocrinology; 1990 Dec; 127(6):2876-83. PubMed ID: 1701131
[TBL] [Abstract][Full Text] [Related]
16. Oestrogen secreting Leydig cell tumour and GnRH agonist in-vivo and in-vitro studies.
Kerlan V; Nahoul K; Abalain JH; Mangin P; Bercovici JP
Clin Endocrinol (Oxf); 1992 Sep; 37(3):221-6. PubMed ID: 1424204
[TBL] [Abstract][Full Text] [Related]
17. Suppression of plasma gonadotropins and testosterone in adult male monkeys (Macaca fascicularis) by a potent inhibitory analog of gonadotropin-releasing hormone.
Adams LA; Bremner WJ; Nestor JJ; Vickery BH; Steiner RA
J Clin Endocrinol Metab; 1986 Jan; 62(1):58-63. PubMed ID: 3079603
[TBL] [Abstract][Full Text] [Related]
18. Regulation of testicular steroidogenesis by gonadotropin-releasing hormone agonists and antagonists.
Huhtaniemi I; Nikula H; Rannikko S; Clayton R
J Steroid Biochem; 1986 Jan; 24(1):169-76. PubMed ID: 3009972
[TBL] [Abstract][Full Text] [Related]
19. Treatment of prostatic cancer with a gonadotropin-releasing hormone agonist analog: acute and long term effects on endocrine functions of testis tissue.
Huhtaniemi I; Nikula H; Rannikko S
J Clin Endocrinol Metab; 1985 Oct; 61(4):698-704. PubMed ID: 2993345
[TBL] [Abstract][Full Text] [Related]
20. Dynamics of plasma gonadotropin and sex steroid release in polycystic ovarian disease after pituitary-ovarian inhibition with an analog of gonadotropin-releasing hormone.
Calogero AE; Macchi M; Montanini V; Mongioi A; Maugeri G; Vicari E; Coniglione F; Sipione C; D'Agata R
J Clin Endocrinol Metab; 1987 May; 64(5):980-5. PubMed ID: 3104389
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
